Quantum BioPharma Ltd.
QNTM
$18.09
$0.0350.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.53M | 3.54M | 7.20M | 6.61M | 3.33M |
| Total Receivables | 3.23M | 3.41M | 3.81M | 7.09M | 6.56M |
| Inventory | 76.90K | 93.90K | 117.20K | -- | -- |
| Prepaid Expenses | 425.40K | 118.00K | 42.70K | 103.50K | 130.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 5.08M | 2.77M | 887.60K | 46.80K | -- |
| Total Current Assets | 10.34M | 9.93M | 12.05M | 13.84M | 10.02M |
|
|
|||||
| Total Current Assets | 10.34M | 9.93M | 12.05M | 13.84M | 10.02M |
| Net Property, Plant & Equipment | 228.20K | 109.30K | 130.40K | 137.30K | 73.10K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 4.73M | 4.83M | 4.93M | 5.04M | 5.15M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 15.30M | 14.87M | 17.12M | 19.03M | 15.25M |
|
|
|||||
| Total Accounts Payable | 1.87M | 1.32M | 3.25M | 1.35M | 3.60M |
| Total Accrued Expenses | 1.32M | 1.04M | 1.11M | 1.96M | 816.60K |
| Short-term Debt | 1.94M | 1.09M | 619.00K | 300.50K | 615.60K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 320.60K | 192.30K | 205.90K | 72.50K | 9.60K |
| Total Finance Division Other Current Liabilities | 7.79M | 6.71M | 1.49M | 100.00 | 0.00 |
| Total Other Current Liabilities | 7.79M | 6.71M | 1.49M | 100.00 | 0.00 |
| Total Current Liabilities | 13.25M | 10.34M | 6.68M | 3.68M | 5.04M |
|
|
|||||
| Total Current Liabilities | 13.25M | 10.34M | 6.68M | 3.68M | 5.04M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.94M | 1.09M | 619.00K | 300.50K | 615.60K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 13.25M | 10.34M | 6.68M | 3.68M | 5.04M |
|
|
|||||
| Common Stock & APIC | 192.54M | 184.99M | 181.54M | 180.21M | 171.36M |
| Retained Earnings | -189.94M | -180.69M | -172.11M | -166.75M | -162.92M |
| Treasury Stock & Other | 1.16M | 1.43M | 2.05M | 2.83M | 2.52M |
| Total Common Equity | 3.76M | 5.73M | 11.48M | 16.29M | 10.96M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.76M | 5.73M | 11.48M | 16.29M | 10.96M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -1.72M | -1.20M | -1.04M | -944.30K | -756.10K |
| Total Equity | 2.05M | 4.53M | 10.44M | 15.35M | 10.20M |
|
|
|||||